Royal Decree amending the Royal Decree of 11 May 2021 implementing Article 3 (2) of the Law of 22 December 2020 concerning various measures relating to rapid antigen tests and the recording and processing of data relating to vaccinations in the context of the fight against the COVID-19 pandemic FILIP, King of Belgium, to all who are now and will be listed below, Our Greet. Having regard to the Law of 15 December 2013 relating to medical devices, Article 50, paragraph 1; Having regard to the Law of 22 December 2020 concerning various measures relating to rapid antigen tests and to the recording and processing of data relating to vaccinations in the context of the fight against the COVID-19 pandemic, Article 3, § 2; Having regard to the Opinion of the Finance Inspectorate, given on 23 June 2021; Having regard to the laws of the State, coordinated on 12 January 1973, § 1; Considering the urgency of the fact that this draft relates to an extraordinary crisis situation, namely the COVID-19 pandemic currently prevailing in Belgium, which provides for special and serious difficulties in respect of the grounds of the principle of the22 December 2020 concerning various measures relating to rapid antigen testing and the recording and processing of data relating to vaccinations in the context of the fight against the COVID-19 pandemic is replaced by the following: "Art. 2. The sale and delivery of self-testing shall be carried out in accordance with the legislation applicable to in vitro diagnostic medical devices, as defined by Article 1 (2) 2° of the Royal Decree of 14 November 2001 on in vitro diagnostic medical devices." Article 2. This Decision shall enter into force on the day following its publication in the Belgian Official Journal.